首页> 外文期刊>Biochimica et biophysica acta. Biomembranes >The application of solid-state NMR spectroscopy to study candesartan cilexetil (TCV-116) membrane interactions. Comparative study with the AT1R antagonist drug olmesartan
【24h】

The application of solid-state NMR spectroscopy to study candesartan cilexetil (TCV-116) membrane interactions. Comparative study with the AT1R antagonist drug olmesartan

机译:固态NMR光谱技术在研究坎地沙坦酯(TCV-116)膜相互作用中的应用。与AT1R拮抗剂药物奥美沙坦的比较研究

获取原文
获取原文并翻译 | 示例
           

摘要

AT1 receptor (AT1R) antagonists exert their antihypertensive effects by preventing the vasoconstrictive hormone AngII to bind to the AT1 receptor. It has been proposed that these biological effects are mediated through a two-step mechanism reaction. In the first step, they are incorporated in the core of the lipid bilayers and in the second step they reach the active site of the receptor through lateral diffusion. In this model, drug/membrane interactions are key elements for the drugs achieving inhibition at the AT1 receptor. In this work, the interactions of the prodrug candesartan cilexetil (TCV-116) with lipid bilayers are studied at molecular detail. Solid-state 13C-CP/MAS, 2D 1H-1H NOESY NMR spectroscopy and in silico calculations are used. TCV-116 and olmesartan, another drug which acts as an AT1R antagonist are compared for their dynamic effects in lipid bilayers using solid-state 2H-NMR. We find a similar localization of TCV-116 compared to other AT1 antagonists in the intermediate polar region. In addition, we can identify specific local interactions. These interactions may be associated in part with the discrete pharmacological profiles observed for different antagonists.
机译:AT1受体(AT1R)拮抗剂通过阻止血管收缩激素AngII结合AT1受体发挥其降压作用。已经提出这些生物学作用是通过两步机理反应来介导的。第一步,将它们掺入脂质双层的核心,第二步,它们通过横向扩散到达受体的活性位点。在该模型中,药物/膜相互作用是药物在AT1受体处获得抑制的关键因素。在这项工作中,在分子细节上研究了前药坎地沙坦西酯(TCV-116)与脂质双层的相互作用。使用固态13C-CP / MAS,2D 1H-1H NOESY NMR光谱和计算机计算。使用固态2H-NMR比较了TCV-116和奥美沙坦(作为AT1R拮抗剂的另一种药物)在脂质双层中的动态作用。我们发现在中间极性区域与其他AT1拮抗剂相比,TCV-116的定位相似。此外,我们可以识别特定的本地互动。这些相互作用可能部分与针对不同拮抗剂观察到的离散药理学特征相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号